Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Al-Azhar University
Methods: all patients in the study will subject to:
* Clinical assessment, WT, Height ,BMI, parity, medications,
* DAS 28.
* Serum 14-3-3η protein.
* DEXA scan.
Grouping:
* Group I: RA Patients with low BMD.
* Group II: RA Patients with normal BMD.
* Group III: normal control.
Age
16–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Rheumatoid arthritis according to ACR 2010 criteria with at least one year duration.
Premenopausal females.
On conventional DMARD with maximum 5 mg steroids.
You may not be if
Biological treatment.
Previous antiresorptive treatment, or bone anabolics.
